New AR game aims to keep aging brains sharp
NCT ID NCT07530315
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests Exercogs®, a digital game that uses augmented reality to combine mental challenges, physical exercise, and social interaction. Researchers will enroll 150 adults aged 55 and older who have at least one risk factor for dementia. Participants will play the game three times a week for 24 weeks, and their cognitive function, physical performance, and social participation will be measured. The goal is to see if this fun, tech-based approach can help prevent cognitive decline.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Exercogs® (augmented reality exergame combining cognitive, physical, and social activities)
- What this could lead to
- If effective, Exercogs® could become a scalable, community-based program to help older adults at risk of dementia maintain their cognitive and physical health.
- What could go wrong
- This is a relatively small, early-stage trial (150 participants) testing a novel digital intervention. The control group also gets supervised exercise, so the added benefit of the AR component may be small. Results are not expected until 2026.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 55 years or older * Presence of ≥1 modifiable risk factor according to the Lancet Commission on Dementia Prevention, Intervention, and Care (2024): low education, untreated hearing or visual loss, hypertension, obesity, smoking, depression, physical inactivity, type 2 diabetes, social isolation, excessive alcohol consumption, history of head trauma, air pollution exposure, high LDL/dyslipidemia; additional social and structural determinants, including poverty, income inequality, wealth shocks, and HIV, that may also contribute to risk (Mostert et al., 2025); * Ability and willingness to participate in 60-minute sessions, three times per week, during the 24-week intervention period; * Ability to provide written informed consent, or, in cases of reduced decisional capacity, provision of consent by a legally authorized representative. Exclusion Criteria: * Clinical diagnosis of Alzheimer's disease or dementia; * Severe neurological disorder or unstable medical condition that may interfere with participation; * Sensory or language deficits that would prevent understanding of instructions or safe participation; * Current participation in another interventional study that may confound outcomes (e.g., cognitive training, physical exercise, or multidomain rehabilitation); * Previous experience with Exercogs®.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dementia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Irmãs Hospitaleiras - Casa de Saúde da Idanha
RECRUITINGSintra, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple gel meets the Mouth's microscopic zoo
- Can a Phone-Based sleep program help dementia caregivers rest better?
- Can a video chat keep dementia care true to Patients' wishes?
- Can a web platform teach students to make better dementia care decisions?
- Can better training get doctors to talk about what matters most to dying veterans?
- Eye scans as a window to the body: study probes retinal imaging across diseases